ACUTE ISCHEMIC STROKE

This study tests a new device called the RapidPulse Aspiration System, which uses precisely timed suction to remove blood clots from brain arteries in people having a severe stroke. The trial will enroll 170 adults aged 18 to 80 who can be treated within 8 hours of stroke symptom…

This study tests whether giving a second dose of the clot-busting drug prourokinase can help stroke patients who have a blocked medium or large artery and don't show improvement one hour after the first dose. About 122 adults will be enrolled within 4.5 hours of stroke onset. The…

This study tests whether starting virtual reality-based rehabilitation within 24 hours of an acute ischemic stroke can improve arm muscle strength, thinking skills, and motivation to exercise. One hundred adults recently diagnosed with stroke will be randomly assigned to either v…

This study tests whether adding GM1, a natural brain substance, to standard clot-removal treatment helps people recover better after a severe stroke. About 868 adults in China who have a blocked artery in the front part of the brain will receive either GM1 or a placebo daily for …

This study tests whether the drug sivelestat sodium, given alongside standard clot-removal surgery, can help people recover better after a major stroke. The trial will include 868 adults aged 18-80 with large-vessel blockage in the front part of the brain. The goal is to see if t…

This Phase 3 trial tests whether sovateltide, a drug that stimulates ETB receptors, can improve recovery after an acute ischemic stroke. About 514 adults aged 18-80 will receive either sovateltide or a placebo alongside standard care. The main goal is to see if more patients achi…

This study compares a new 'virtual stroke unit' approach to standard stroke unit care for people with a stroke who are not eligible for a clot removal procedure. The virtual unit uses video calls and monitoring equipment to let a specialist team at a main hospital help guide care…

This study tests a drug called tenecteplase (TNK) for people who have had a stroke caused by a blood clot in the brain. The drug is given up to 24 hours after symptoms start, using only a simple CT scan to decide who can get it. The goal is to see if TNK helps people recover bett…

This study tests whether removing a blood clot from the brain up to 72 hours after a stroke can help patients recover better than standard care. About 336 adults with severe strokes due to a large vessel blockage will be randomly assigned to get the clot removal procedure or usua…

This study tests whether the clot-busting drug tenecteplase can help people who have a stroke more than 4.5 hours ago, including those who wake up with stroke symptoms. About 1,325 adults with brain imaging showing salvageable tissue will be randomly assigned to receive tenectepl…

This early-stage trial tests whether stem cells from the placenta, given through an IV, are safe and might help people recover from a recent stroke. About 24 participants will receive either the stem cells or a placebo. Researchers will track their recovery over two years, focusi…

This study tests whether a clot-busting drug called tenecteplase can help people who have a stroke affecting the back part of the brain. Participants must start treatment between 4.5 and 24 hours after their first symptoms. The goal is to see if the drug improves recovery and dai…

This study tests a nurse-led program called BEST CARE ICTUS_HC for adults hospitalized with acute stroke in hospitals without specialized stroke units. The program includes staff training, swallowing tests, and environmental adaptations to help with attention and safety. Research…

This study tests whether the antibiotic minocycline can improve recovery in people who have had a major stroke and undergone a procedure to remove a blood clot from a large brain artery. Even when the clot is successfully removed, many patients still have significant disability. …

This study tests whether adding the antibiotic minocycline to standard stroke treatment can improve recovery in people who had a severe stroke in the back of the brain. After a clot is removed, brain inflammation can limit healing. Minocycline may reduce that inflammation. The tr…

This study tests whether placing a stent in the brain artery after removing a clot can improve recovery for people having a severe stroke. About 342 adults aged 18-80 with a blocked large artery and significant residual narrowing will be randomly assigned to get either standard c…

This early-stage study tests whether a drug called anisodine hydrobromide is safe for people having a stroke caused by a blocked large artery in the brain. About 92 adults aged 18 to 80 who are already scheduled for a clot-removal procedure will receive the drug. The main goal is…

This study tests whether starting heart rhythm control therapy soon after a stroke can prevent future strokes, heart-related deaths, or hospital stays in people with atrial fibrillation. About 1,746 participants will receive either early comprehensive treatment or usual care. The…

This study tests a new drug called BB-031 in people who have had a stroke within the last 24 hours. About 228 participants will receive either the drug or a placebo, and researchers will check for safety, side effects, and how the drug works in the body over 90 days. The main goa…

This study tests an experimental drug called QD202 in people who have had an acute ischemic stroke and received clot-busting medication. The drug is designed to cross into the brain and protect nerve cells. About 120 participants will receive either QD202 or a placebo daily for 5…

This study is testing whether using a blood test to guide antiplatelet therapy can better prevent recurrent strokes in people who have had a mild stroke or transient ischemic attack (TIA). About 5,100 participants will be assigned to either standard clopidogrel or ticagrelor base…

This study tests whether tilting a stroke patient's head down 15 degrees for 30-90 minutes before a clot removal procedure can improve blood flow to the brain. About 118 adults with a specific type of stroke will be randomly assigned to either the head-down tilt or standard posit…

This study tests whether a procedure to reopen a major blocked artery in the brain can help people who had a severe stroke 24 to 72 hours earlier. About 224 participants will either get the procedure plus standard care or standard care alone. The goal is to see if the procedure i…

This study tests a new treatment for people who have had a stroke caused by a blood clot in the brain. A weak electrical current is applied through electrodes on the scalp to increase blood flow and protect brain tissue. The goal is to find the safest and most effective dose. The…

This study compares a procedure to remove blood clots (endovascular therapy) with standard medical care for people who have had a mild stroke caused by a blockage in a large brain artery. About 264 adults with mild symptoms (NIHSS score 2-5) will be enrolled within 24 hours of st…

This study compares two ways to reach a blood clot in the basilar artery, a key vessel at the back of the brain, during a stroke. One method uses the femoral artery in the groin, the other uses the radial artery in the wrist. Researchers want to see which approach leads to better…

This Phase II trial tests a drug called LT3001 in 300 people who have had an acute ischemic stroke. Participants receive either a high or low dose of LT3001 or a placebo by IV infusion within 24 hours of their stroke. The study aims to see if the drug is safe and helps improve re…

This study looks at whether adding evolocumab (a powerful cholesterol-lowering drug) to standard statin therapy helps people recover better after a stroke caused by hardening of the large arteries. Researchers will follow 1000 adults aged 18-80 for 90 days, comparing those who ge…

This phase 2 trial is testing whether TAK-755, a lab-made protein that helps break up blood clots, is safe and effective for people who have had an acute ischemic stroke. About 222 adults aged 18 to 80 will receive either TAK-755 or a placebo, along with standard stroke care, and…

This study is testing a device called EmboTrap II, which is used to remove blood clots from the brain in people having a stroke. The goal is to see if it is safe and works well at restoring blood flow. About 100 participants will be followed to track outcomes like bleeding and su…

This study tests whether adding a clot-dissolving medicine directly into the brain's arteries during standard clot-removal procedures helps people recover better after a stroke caused by a medium-sized blockage. About 530 adults with acute ischemic stroke will be randomly assigne…

This study tests whether giving the protein albumin (given as an IV drip for four days) along with standard clot-removal treatment helps people recover better after a severe stroke caused by a large blockage. About 1,200 adults aged 18-80 with anterior circulation strokes will be…

This study tests whether using remote-controlled CT scans at local medical centers, guided by a hospital stroke team via video call, can speed up treatment for stroke patients. About 52 participants with suspected stroke will be randomly assigned to either this new approach or st…

This study tests whether removing a blood clot from the brain (endovascular thrombectomy) plus standard medical care helps people who had a severe stroke 24 to 72 hours earlier. About 408 adults aged 18-85 with large-vessel blockage will be randomly assigned to get the procedure …

This study is testing a device called the NeVa stent retriever to see how well it can remove blood clots in people having a severe stroke. The goal is to restore blood flow to the brain in a single pass. The study will enroll 600 adults who are already scheduled to have this proc…

This study tests whether the clot-busting drug tenecteplase can help people who have had a stroke 24 to 72 hours earlier. Currently, such drugs are only given within a few hours. The trial will compare tenecteplase to standard care (blood thinners) in 330 adults with blocked brai…

This study looks at 100 people who recently had a stroke and need surgery to clear a blocked neck artery. Half will get numbing medicine only in the neck (regional anesthesia), and the other half will be fully asleep (general anesthesia). The goal is to see which method leads to …

This study tests a new device called Ceretrieve that is designed to remove blood clots from brain arteries in people having a severe stroke. About 132 participants will be treated within 24 hours of symptoms starting. The goal is to see if the device can safely restore blood flow…

This study tests whether giving a clot-busting drug (tenecteplase) before transferring patients with a severe stroke in the back of the brain (basilar artery occlusion) to a specialized hospital can improve recovery. About 316 adults who had a stroke 4.5 to 24 hours earlier will …

This study looks at whether giving a clot-dissolving drug called Tenecteplase to stroke patients before they are moved to a hospital that can perform a clot-removal procedure improves their recovery. The trial involves 572 adults who had a stroke caused by a large blockage in the…

This study tests a drug called JX10 in people who have had a stroke and arrive at the hospital 4.5 to 24 hours later. The goal is to see if JX10 can improve recovery and reduce disability compared to a placebo. About 740 participants will be randomly assigned to receive JX10 or a…

This study compares a stent (CARESTO® heal) plus standard medication against medication alone in 536 people who recently had a stroke or retinal artery blockage due to a specific type of carotid artery disease that is not severely narrowed. The goal is to see if the stent can low…

This study tests whether adding a fast-acting blood thinner (cangrelor) to standard clot removal improves recovery in people with a severe stroke. About 368 adults with a large artery blockage in the brain will receive either cangrelor plus the procedure or the procedure alone. T…

This study is testing a new medical device system designed to quickly restore blood flow in people having a severe stroke caused by a blocked artery. About 500 adults who are treated within 8 hours of stroke symptoms will be enrolled. The goal is to see how well the device reopen…

This study looks at whether removing a blood clot from a medium-sized brain artery (M2 segment) helps people recover better after a stroke. About 200 adults who have had a stroke and are not helped by clot-busting medicine will be randomly assigned to get either standard care or …

This study looks at whether giving clot-busting drugs to stroke patients who are already on blood thinners is safe and effective. About 260 adults who had a stroke while taking common blood thinners will be enrolled. The goal is to see if this treatment can improve recovery witho…

This study looks at stroke patients who had a clot successfully removed from a large brain artery. After the procedure, some patients have low blood pressure. The trial will test whether carefully raising their blood pressure by 20% (but not above 160 mmHg) leads to better recove…

This study tests a new drug called QHRD106 in people who have had a recent ischemic stroke (a stroke caused by a blocked blood vessel in the brain). The goal is to see if the drug can help patients recover better and have less disability. About 320 adults aged 18 to 80 who have n…

This study tests whether telemedicine support can improve stroke care in basic-level hospitals with limited resources. About 2,400 patients with acute ischemic stroke will be treated at hospitals that either receive round-the-clock remote guidance from expert stroke teams or do n…

This study tests a single injection of stem cells (B2065) given within 36 hours of a stroke. The goal is to see if it is safe and might help patients recover better. Fifty-four adults with moderate to severe stroke will receive either the stem cells or a placebo, and be followed …

This study tests whether a procedure to remove a blockage in the neck artery (endovascular treatment) plus standard medical care helps people recover better after a stroke. About 200 adults with acute ischemic stroke from a blocked internal carotid artery will be randomly assigne…

This study tests a new device called the iNstroke 4F catheter, designed to remove blood clots from small blood vessels deep in the brain after a stroke. About 57 adults who have had a stroke within the past 24 hours will receive this treatment. The goal is to see if the catheter …

This study tests whether giving a clot-busting drug directly into the brain's arteries can help people having a stroke from a medium-sized blockage. About 382 adults who have had a stroke within the last 24 hours will be randomly assigned to receive either the drug or standard ca…

This study tests a new way to manage blood pressure in people having a stroke who receive clot-busting medication. The goal is to see if adjusting blood pressure treatment can lower the risk of bleeding in the brain. About 340 participants will be randomly assigned to either the …

This study looks at whether two different versions of Angong Niuhuang Pills can help people recover from an acute ischemic stroke. About 100 adults aged 18-80 will take one of the two pill types or receive no pills, and their recovery will be tracked for 84 days. The goal is to s…

This large Phase 3 trial is testing whether an investigational drug called SHPL-49 can help people recover better after an acute ischemic stroke. About 1,096 participants will receive either the drug or a placebo as an IV infusion twice daily for 7 days, alongside standard care. …

This study tests whether umbilical cord stem cells (Neuroncell-EX) can improve recovery in people who recently had a moderate to severe stroke. Eighty participants will receive either the stem cells or a placebo, plus standard care. The goal is to see if the treatment helps with …

This study tests whether giving the blood thinner tirofiban soon after standard clot-busting medication helps people recover better from a stroke. About 1,084 adults with moderate stroke symptoms will receive either tirofiban or a placebo within 6 hours of the initial treatment. …

This study tests whether a drug called tenecteplase can help people who have had a stroke and cannot get treatment within the usual 4.5-hour window. About 890 Chinese adults with a moderate to severe stroke will receive either the drug or standard care. Doctors will use a special…

This study looks at whether giving the drug tirofiban soon after the standard clot-busting drug tenecteplase can help people recover better from a stroke. About 348 adults who had a stroke and received tenecteplase will be enrolled. The goal is to see if this combination reduces …

This study tests whether adding the blood thinner tirofiban after standard clot-busting treatment helps people with acute ischemic stroke recover better. About 976 adults whose stroke symptoms don't improve enough within an hour of initial treatment will receive either tirofiban …

This study tests whether giving aspirin within 3 hours of clot-busting treatment for stroke can improve recovery without causing dangerous bleeding. About 1,184 adults who had an ischemic stroke will receive either aspirin or a placebo. The goal is to see if early aspirin leads t…

This Phase 3 trial tests a drug called rhTNK-tPA (Mingfule) in people with acute ischemic stroke who can be treated 4.5 to 24 hours after symptoms start. The study plans to enroll 890 participants and will compare the drug to a placebo. The goal is to see if the drug helps patien…

This Phase 3 trial tests whether adding carotid artery stenting to standard mechanical clot removal improves recovery in people with acute ischemic stroke caused by a blockage in the internal carotid artery. About 404 participants aged 18-79 will be randomly assigned to receive e…

This study tests a drug called tenecteplase in people who have had a stroke and recently took a blood thinner (DOAC). The goal is to see if the drug helps them recover better after 90 days. About 912 participants will receive either tenecteplase or a placebo within 24 hours of th…

This study tests an experimental drug called KPCXM18 in people who have had an acute ischemic stroke within the past 12 hours. About 300 participants will receive either a low dose, a high dose, or a placebo by IV twice daily for about 12 days. The main goal is to see if the drug…

This study tests whether a noninvasive arm cuff therapy, called remote ischemic conditioning, can improve recovery in people who have had a major stroke and undergone a clot-removal procedure. The therapy involves briefly inflating and deflating a cuff on the upper arm to protect…

This early-stage trial tests whether exosomes from stem cells can help people recover from a recent stroke. 29 participants will receive either the exosome treatment or a placebo, and researchers will check for safety and any signs of improved function. The study is small and exp…

This study tests whether a traditional Chinese herbal formula called Qingre Huatan can prevent early neurological deterioration in people who have had an acute ischemic stroke within the last 48 hours. The trial will involve 72 participants, who will receive either the herbal gra…

This study tests a new drug called TBO-309, which helps prevent blood clots, in people having a stroke. It is given alongside standard treatments like clot-busting drugs or mechanical clot removal. The main goal is to see if it is safe, especially regarding bleeding in the brain,…

This study tests increasing doses of the clot-busting drug urokinase in 24 people with acute ischemic stroke, given within 6 hours of symptoms. The goal is to find the highest safe dose and develop a weight-based dosing plan. Researchers will watch closely for bleeding complicati…

This study tests a new drug called MT200605 in 360 people who have had an acute ischemic stroke within the past 24 hours. The drug aims to protect brain cells and reduce damage from the stroke. Participants will receive either a high, medium, or low dose of the drug or a placebo,…

This study tests whether adding the drug tirofiban after a standard clot-removal procedure helps people recover better from a severe stroke caused by a blocked artery. About 716 adults will receive either tirofiban or a placebo right after the procedure. The main goal is to see i…

This study tests whether giving the steroid methylprednisolone right after a stroke clot removal procedure can help patients recover better. About 1060 adults who had a large-vessel stroke will receive either the drug or a placebo. The goal is to see if the drug reduces disabilit…

This study tests a new device called the CONDA stent retriever, which is used to remove blood clots from the brain in people having a stroke. About 50 patients will be treated within 24 hours of their symptoms starting. The goal is to see if the device is safe and works well at r…

After a stroke, patients are at high risk of having another one, especially in the first 21 days. This study tests whether adding clopidogrel to the standard aspirin treatment is safe and feasible for preventing a second stroke. About 200 patients who had a mild to moderate strok…

This study tests whether clot-busting drugs (alteplase or tenecteplase) are safe and effective for stroke patients who have taken a blood thinner (FXa inhibitor) in the last 48 hours. Current guidelines avoid this treatment due to bleeding concerns, but new evidence suggests it m…

This study tests whether a sublingual tablet called edaravone dexborneol can help prevent or reduce thinking problems that often occur after a stroke. About 226 people who recently had a stroke and already show some cognitive issues will take the tablet or a placebo twice daily f…

This Phase 2 trial tests whether the drug Aleeto can improve neurological function in people who have had a moderate to severe ischemic stroke. About 192 participants will receive either Aleeto or a placebo by IV within 72 hours of their stroke. The main goal is to see if Aleeto …

This trial tests a wearable bracelet called Stroke Alarm that detects when a stroke causes arm weakness. People aged 50 and older with certain high-risk conditions (like recent mini-stroke, atrial fibrillation, or artery disease) wear the device for 3 months. The goal is to see i…

This study is looking for markers in blood and saliva that can quickly tell if a person is having a stroke, and what kind. Researchers will collect samples from 650 adults with suspected stroke within 24 hours of symptoms. The goal is to develop a fast, accurate test to help emer…

This study looks at whether monitoring brain blood flow during stroke treatment can predict if a patient will recover well. Researchers will track 129 stroke patients for 90 days after treatment. The goal is to find a way to identify early on who might need extra care.

This study looks at whether a special type of CT scan (multimodal CT) can more accurately identify the blocked artery in people with medium vessel occlusion stroke. Researchers will compare this method to standard CT scans in 622 adults who had a stroke within the last 24 hours. …

This early-phase trial tests whether inhaled nitric oxide is safe for people having emergency clot removal after a stroke. It includes 36 adults with severe strokes. The main goal is to find the highest safe dose without causing brain bleeding.

This study tests whether extra support—like personalized mask fitting, monthly phone calls, and a tracking app—helps stroke patients with sleep apnea use their CPAP machine more consistently during rehab. About 250 participants will be randomly assigned to either this intensive s…

This study looks at two different ways to keep patients comfortable and calm during a procedure to remove a blood clot from the brain after a stroke. The goal is to find out which method helps patients recover better and have fewer problems. About 810 adults having this emergency…

This study tests whether a gentle electrical current applied to the scalp (tDCS) combined with computer-based cognitive training can improve memory, attention, and thinking in people who had a mild stroke. About 60 participants will receive either real tDCS or a sham (fake) versi…

This study is a registry that will follow 1500 adults treated for acute ischemic stroke with Medtronic devices. Researchers will track safety, how well the devices restore blood flow, and whether patients regain independence after 90 days. The goal is to see how these devices wor…

This study uses a brain imaging technique called MEG to look at how the brain recovers after a minor stroke. Researchers will scan 40 stroke survivors and 15 healthy older adults at 1, 6, and 12 months after the stroke while they perform a naming task. The goal is to understand w…

This study tests whether adding immersive virtual reality (VR) to standard physical therapy helps people who recently had a stroke regain arm movement and improve quality of life. Researchers will also look at blood markers and genes that might predict recovery. About 120 adults …

This observational study at Yale University will follow 150 people who have had an ischemic stroke to see how changes in blood pressure affect their recovery. Researchers will use brain scans and thinking tests to understand the connection. The goal is to find better ways to mana…

This study looks at how a stroke can disrupt the body's automatic functions, like heart rate and blood pressure control. Researchers will compare 100 people who had a stroke or a mini-stroke using brain scans, blood tests, and heart function tests. The goal is to understand why t…

This study follows 24 people who had a stroke and were recently diagnosed with atrial fibrillation (AF), a heart rhythm problem. Researchers want to see how AF changes over two years by monitoring heart activity, blood markers, and heart structure. The goal is to better understan…

This study compares how well stroke neurologists and a deep learning AI model predict recovery in 250 stroke patients. Researchers will track actual disability at 24 hours and 3 months, then compare those results to predictions made by doctors and the AI. The goal is to understan…

This study is testing a new, non-invasive brain monitor (Neurosteer) in 100 ICU patients who are on breathing machines and sedatives. The monitor is a small device placed on the forehead that measures brain activity. Researchers want to see if it can accurately track levels of se…

This study looks at why about half of stroke patients don't recover well even after doctors successfully remove a blood clot from their brain. Researchers will use special MRI scans to measure blood flow changes in the brain at 3 days, 7 days, and 90 days after the procedure. The…

This study is testing whether a gentle electrical stimulation of a nerve in the ear (the vagus nerve) can reduce brain injury and inflammation after a severe stroke. Researchers will measure brain damage markers in the blood of 65 participants over a week. The goal is to see if t…

This study collects data from 336 adults aged 18-85 who had an acute ischemic stroke and received a new clot-busting drug called non-immune staphylokinase. Researchers will check how often bleeding in the brain occurs and compare results to the standard drug alteplase. The goal i…

This study is looking for 250 stroke survivors to understand why many feel overwhelming tiredness after a stroke, known as post-stroke fatigue. Researchers will measure heart rate variability, heart function, and blood markers to see if problems with the autonomic nervous system …

The PREVENT study is a large, worldwide registry that will track 1,000 stroke patients who undergo a clot-removal procedure called thrombectomy. Researchers want to understand why a blood vessel sometimes gets poked during the procedure, causing dangerous bleeding. By studying me…

This study tests whether a 3D image overlay (fusion imaging) helps doctors reach and remove blood clots in the brain faster during a standard stroke procedure. About 300 adults having emergency clot removal will be randomly assigned to get the extra imaging or not. The goal is to…

This study collects blood, clots, and tissue from up to 1000 people having procedures for stroke or other blood vessel problems in the brain. Researchers will analyze these samples to find biological markers and understand inflammation. The goal is to learn more about how stroke …

This study is looking back at medical records of 2,600 stroke patients who received clot-busting drugs between 4.5 and 24 hours after their stroke started. The goal is to see if giving the drug later than the usual 4.5-hour window can still lead to good recovery. The study does n…

This study is collecting information from 1,000 people who have been treated for brain aneurysms or stroke using MicroVention devices. The goal is to see how well these treatments work in real life, not just in controlled trials. No new treatments are being tested—just data gathe…

This study aims to create a tool that predicts if someone will develop depression after an ischemic stroke. Researchers will use machine learning to analyze data from 488 participants. The goal is to help doctors identify at-risk patients early and improve recovery.

This study looks at whether giving antibiotics for just 24 hours around the time of placing a special antibiotic-coated brain drain works as well as giving them for the whole time the drain is in place. The goal is to find the best way to prevent serious brain infections in peopl…

This study is testing a new type of MRI scanner, called Field-Cycling Imaging (FCI), to see if it can detect brain changes within the first day of a stroke. Researchers will compare FCI scans with standard MRI scans in 40 acute stroke patients. Participants will also provide bloo…

This study looks at brain tissue and MRI scans from 15 people who had a severe stroke and needed surgery. Researchers want to understand if certain dark spots on MRI are caused by tiny blood clots or bleeding. The goal is to learn more about what happens in the brain after a stro…

This study looks at blood clots removed from stroke patients during a procedure called thrombectomy. Researchers will also take a small blood sample. They want to see if the clot's makeup and blood markers can tell us more about what caused the stroke, how well treatment worked, …

This study is collecting data from 5,000 people who had a stroke caused by a blood clot and received endovascular treatment (a procedure to remove the clot). The goal is to measure how well patients recover neurologically three months later. This information is rarely collected b…

This study will track 10,000 adults who receive tenecteplase for a stroke caused by a blood clot. Researchers want to see how well patients recover and if there are any safety issues when the drug is used in everyday hospital care. The goal is to improve stroke treatment across C…

This study aims to create an AI system that predicts which type of rehabilitation—like standard therapy, electrical stimulation, robotic training, or acupuncture—will help each stroke survivor recover the most movement in their arm. Researchers will collect data from 400 stroke s…

This study will use routine EEG recordings in 100 stroke patients to see if brain activity patterns can predict who will develop epilepsy. Researchers also aim to detect hidden (subclinical) seizures that may affect recovery. The study is observational, meaning no new treatment i…

This study is collecting information from up to 10,000 people who receive BALT medical devices for conditions like brain aneurysms, stroke, and blocked arteries. Researchers will track how well the devices work and if any safety issues arise during routine care. The goal is to ga…